FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileHealius Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HLS.AX
Healius Limited Stock AnalysisComprehensive stock analysis for Healius Limited (HLS.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHLS.AX
HLS.AX
Healius Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HLS.AX
  1. Home
  2. Stocks
  3. Healius Limited

Healius Limited

🇦🇺HLS.AX•ASX

Healius Limited

🇦🇺HLS.AX•ASX

Your view on HLS.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Healius Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Paul D. Anderson
Headquarters
161 Castlereagh Street, Sydney, NSW, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Paul D. Anderson
Headquarters
161 Castlereagh Street, Sydney, NSW, AU
Description

Healius Limited is an Australian firm dedicated to delivering specialized diagnostic services to both individual consumers and healthcare practitioners. Its operations are structured into four primary segments: Pathology, Medical Imaging, Day Hospitals, and other miscellaneous services.

The company's core offerings include comprehensive diagnostic imaging, private medical laboratory analysis, and various pathology services.

Furthermore, under a diverse portfolio of brands such as Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs, alongside Lumus Imaging and Montserrat, Healius also facilitates a wide array of specialized surgical procedures.

These encompass cataract removal, colonoscopies, gastroscopies, plastic and cosmetic operations, skin cancer excisions, IVF egg collection, and gynecological surgeries. The company boasts an extensive network across Australia, comprising 2,105 pathology facilities, 11 day hospitals, and 134 imaging centers.

Established in 1994, the entity was originally known as Primary Health Care Limited, adopting the Healius Limited name in December 2018. Its corporate headquarters are situated in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Healius Limited. Starting points for Healius Limited: EPS -AUD 0.57, beta 0.28 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Healius Limited. Healius Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Healius Limited. Trailing twelve-month EPS for Healius Limited stands at -AUD 0.57. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00−AUD 0.00−AUD 0.01−AUD 0.00
Lowest estimateAUD 0.00−AUD 0.00−AUD 0.13−AUD 0.01
Highest estimateAUD 0.00−AUD 0.00AUD 0.04AUD 0.01
Number of analysts0145
A year agoAUD 0.07AUD 0.011−AUD 0.571—
Growth vs a year ago−100.0%———

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 670.66MAUD 687.16MAUD 1.40BAUD 1.43B
Lowest estimateAUD 670.66MAUD 687.16MAUD 1.38BAUD 1.41B
Highest estimateAUD 670.66MAUD 687.16MAUD 1.43BAUD 1.46B
Number of analysts6167
A year agoAUD 998.20MAUD 864.10MAUD 1.37B—
Growth vs a year ago−32.8%−20.5%+1.9%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Healius Limited. Healius Limited has reported as a listed company since 1998. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold HLS.AX20 companies · 8 funds
Compare HLS.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ACL.AXAustralian Clinical Labs LimitedHealthcareMedical - Diagnostics & Research—
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
CTE.AXCryosite LimitedHealthcareMedical - Diagnostics & Research—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
IDX.AXIntegral Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
IIQ.AXINOVIQ LtdHealthcareMedical - Diagnostics & Research—
MVF.AXMonash IVF Group LimitedHealthcareMedical - Diagnostics & Research—
RHY.AXRhythm Biosciences LimitedHealthcareMedical - Diagnostics & Research—
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
TTOOT2 Biosystems, Inc.HealthcareOTC$11,218
TWSTTwist Bioscience CorporationHealthcareNASDAQ$7.7B
VCYTVeracyte, Inc.HealthcareNASDAQ$2.1B
VIMGFVimian Group AB (publ)HealthcareOTC$1.5B
VRCDFVerici Dx plcHealthcareOTC$4.5M
WATWaters CorporationHealthcareNYSE$45.8B
WGSGeneDx Holdings Corp.HealthcareNASDAQ$1.6B
WUXAYWuXi AppTec Co., Ltd.HealthcareOTC$45.6B
WUXIFWuXi AppTec Co., Ltd.HealthcareOTC$39.8B
XGNExagen Inc.HealthcareNASDAQ$99.5M
SKHHYSonic Healthcare LimitedHealthcareOTC$8.2B
SLDXStella Diagnostics Inc.HealthcareOTC$1.4M
ETFs holding Healius Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
ISCFiShares International Small-Cap Equity Factor ETF$717M in assets0.15%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.6B in assets0.00%
GWXState Street SPDR S&P International Small Cap ETF$882M in assets0.03%
FNDCSchwab Fundamental International Small Equity ETF$3.0B in assets0.01%
AVDSAvantis International Small Cap Equity ETF$379M in assets0.01%
VPLVanguard FTSE Pacific ETF$9.0B in assets0.00%

Largest holders first, then the funds most concentrated in HLS.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Healius Limited. Coverage tracks Healius Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Healius Limited.

HLS.AX AnalysisWeak
Past
1
Growth
1
Health
2
Profit
1
Value
1